Joseph Ohayon
Follow
Get notifications in MyBN when activity occurs.
Joseph Ohayon
Joseph Ohayon has over 20 years of experience in financial roles, including 10 years within health related industries. Mr Ohayon qualified as a Chartered Accountant in the UK and graduated with a Masters of Business Administration in International Business from Murdoch University.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 156th | Arovella Therapeutics | 102% | 127% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Arovella Therapeutics | $2.0m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| REMUNERATION UPDATE: Chief Financial Officer, Company Secretary since 2011, Arovella Therapeutics | 02 Nov 2020 |
News Articles
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Chief Financial Officer, Company Secretary since 2011 | | 2010 - 2020 | |
| Executive Director | | 2012 - 2019 | |
| Manager, Corporate Planning | | 2007 - 2009 |
Directors Interests
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| Arovella Therapeutics | 02 Aug 2018 | Issued | 4,806,667 | $0.00 | $24,033 | OtherIssue of securities |
| Arovella Therapeutics | 02 Aug 2018 | Issued | 2,403,333 | OtherIssue of options | ||
| Arovella Therapeutics | 02 Aug 2018 | Sold | 40,000 | $1.06 | $42,333 | OtherProspectus |
| Arovella Therapeutics | 29 Jun 2018 | Bought | 20,000 | $1.00 | $20,000 | OtherAs advised by the company: Private subscription. |
| Arovella Therapeutics | 11 Dec 2017 | Issued | 4,000,000 | OtherIssue of securities |
Powered by Morningstar ®
